5TT8 image
Deposition Date 2016-11-02
Release Date 2017-09-13
Last Version Date 2024-10-16
Entry Detail
PDB ID:
5TT8
Keywords:
Title:
Crystal structure of the complex of Helicobacter pylori alpha-carbonic anhydrase with benzolamide
Biological Source:
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Alpha-carbonic anhydrase
Gene (Uniprot):C694_06140
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:234
Number of Molecules:8
Biological Source:Helicobacter pylori (strain ATCC 700392 / 26695)
Primary Citation
Structure-Activity Relationship for Sulfonamide Inhibition of Helicobacter pylori alpha-Carbonic Anhydrase.
J. Med. Chem. 59 11098 11109 (2016)
PMID: 28002963 DOI: 10.1021/acs.jmedchem.6b01333

Abstact

α-Carbonic anhydrase of Helicobacter pylori (HpαCA) plays an important role in the acclimation of this oncobacterium to the acidic pH of the stomach. Sulfonamide inhibitors of HpαCA possess anti-H. pylori activity. The crystal structures of complexes of HpαCA with a family of acetazolamide-related sulfonamides have been determined. Analysis of the structures revealed that the mode of sulfonamide binding correlates well with their inhibitory activities. In addition, comparisons with the corresponding inhibitor complexes of human carbonic anhydrase II (HCAII) indicated that HpαCA possesses an additional, alternative binding site for sulfonamides that is not present in HCAII. Furthermore, the hydrophobic pocket in HCAII that stabilizes the apolar moiety of sulfonamide inhibitors is replaced with a more open, hydrophilic pocket in HpαCA. Thus, our analysis identified major structural features can be exploited in the design of selective and more potent inhibitors of HpαCA that may lead to novel antimicrobials.

Legend

Protein

Chemical

Disease

Primary Citation of related structures